Literature DB >> 18270341

A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib.

Tejas V Patel, Jeffrey A Morgan, George D Demetri, Suzanne George, Robert G Maki, Michael Quigley, Benjamin D Humphreys.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18270341     DOI： 10.1093/jnci/djm311

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  58 in total

Review 1.  Bevacizumab increases risk for severe proteinuria in cancer patients.

Authors:  Shenhong Wu; Christi Kim; Lea Baer; Xiaolei Zhu
Journal:  J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 10.121

Review 2.  Molecular Mechanisms of Preeclampsia.

Authors:  Tammy Hod; Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

Review 3.  Preeclampsia as a Form of Type 5 Cardiorenal Syndrome: An Underrecognized Entity in Women's Cardiovascular Health.

Authors:  Janani Rangaswami; Mario Naranjo; Peter A McCullough
Journal:  Cardiorenal Med       Date:  2018-04-04       Impact factor: 2.041

Review 4.  Chemotherapy-associated renal dysfunction.

Authors:  Vaibhav Sahni; Devasmita Choudhury; Ziauddin Ahmed
Journal:  Nat Rev Nephrol       Date:  2009-06-30       Impact factor: 28.314

5.  Preeclampsia, gestational hypertension and subsequent hypothyroidism.

Authors:  Tuija Männistö; S Ananth Karumanchi; Anneli Pouta; Marja Vääräsmäki; Pauline Mendola; Satu Miettola; Heljä-Marja Surcel; Aini Bloigu; Aimo Ruokonen; Marjo-Riitta Järvelin; Anna-Liisa Hartikainen; Eila Suvanto
Journal:  Pregnancy Hypertens       Date:  2012-09-21       Impact factor: 2.899

6.  Non-significant impact of proteinuria on renal function in Japanese patients with metastatic renal cell carcinoma treated with axitinib.

Authors:  Hideaki Miyake; Ken-Ichi Harada; Satoshi Imai; Akira Miyazaki; Masato Fujisawa
Journal:  Int J Clin Oncol       Date:  2014-11-26       Impact factor: 3.402

Review 7.  Anti-angiogenesis and Preeclampsia in 2016.

Authors:  Susanne Schrey-Petersen; Holger Stepan
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

8.  ADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy.

Authors:  Luise Erpenbeck; Melanie Demers; Zsuzsanna K Zsengellér; Maureen Gallant; Stephen M Cifuni; Isaac E Stillman; S Ananth Karumanchi; Denisa D Wagner
Journal:  J Am Soc Nephrol       Date:  2015-06-02       Impact factor: 10.121

9.  Rapid development of hypertension and proteinuria with cediranib, an oral vascular endothelial growth factor receptor inhibitor.

Authors:  Emily S Robinson; Ursula A Matulonis; Percy Ivy; Suzanne T Berlin; Karin Tyburski; Richard T Penson; Benjamin D Humphreys
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

10.  Rapid development of hypertension by sorafenib: toxicity or target?

Authors:  Benjamin D Humphreys; Michael B Atkins
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.